glycine has been researched along with Chronic Hepatitis C in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Serum samples from patients with chronic hepatitis C were subjected to metabolomics analysis to clarify the pretreatment characteristics of their metabolites and also changes in specific metabolites resulting from antiviral therapy with pegylated interferon plus ribavirin (PegIFN/RBV)." | 9.17 | Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: a metabolomics analysis. ( Igarashi, K; Katsumi, T; Nishise, Y; Okumoto, K; Saito, K; Saito, T; Sato, C; Shao, L; Soga, T; Sugimoto, M; Tomita, K; Tomita, M; Ueno, Y; Watanabe, H, 2013) |
| "Serum samples from patients with chronic hepatitis C were subjected to metabolomics analysis to clarify the pretreatment characteristics of their metabolites and also changes in specific metabolites resulting from antiviral therapy with pegylated interferon plus ribavirin (PegIFN/RBV)." | 5.17 | Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: a metabolomics analysis. ( Igarashi, K; Katsumi, T; Nishise, Y; Okumoto, K; Saito, K; Saito, T; Sato, C; Shao, L; Soga, T; Sugimoto, M; Tomita, K; Tomita, M; Ueno, Y; Watanabe, H, 2013) |
| "Patients with chronic hepatitis C are expected to receive this treatment worldwide." | 2.52 | Does herbal medicine reduce the risk of hepatocellular carcinoma? ( Rino, Y; Yamamoto, N; Yukawa, N, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Cruz, CES | 1 |
| de Freitas-Silva, L | 1 |
| Ribeiro, C | 1 |
| da Silva, LC | 1 |
| Saito, T | 1 |
| Sugimoto, M | 1 |
| Igarashi, K | 1 |
| Saito, K | 1 |
| Shao, L | 1 |
| Katsumi, T | 1 |
| Tomita, K | 1 |
| Sato, C | 1 |
| Okumoto, K | 1 |
| Nishise, Y | 1 |
| Watanabe, H | 1 |
| Tomita, M | 1 |
| Ueno, Y | 1 |
| Soga, T | 1 |
| Rino, Y | 1 |
| Yukawa, N | 1 |
| Yamamoto, N | 1 |
| Kula, M | 1 |
| Karacavus, S | 1 |
| Baskol, M | 1 |
| Deniz, K | 1 |
| Abdulrezzak, U | 1 |
| Tutus, A | 1 |
| Lampa, A | 1 |
| Ehrenberg, AE | 1 |
| Vema, A | 1 |
| Åkerblom, E | 1 |
| Lindeberg, G | 1 |
| Danielson, UH | 1 |
| Karlén, A | 1 |
| Sandström, A | 1 |
| Matsuzaki, Y | 1 |
| Ikegami, T | 1 |
| Saito, Y | 1 |
| Imazeki, F | 1 |
| Yamada, G | 1 |
3 reviews available for glycine and Chronic Hepatitis C
| Article | Year |
|---|---|
Does herbal medicine reduce the risk of hepatocellular carcinoma?
Topics: Animals; Anti-Inflammatory Agents; Benzimidazoles; Carcinoma, Hepatocellular; Clinical Trials as Top | 2015 |
[Alternative measures for patients with chronic hepatitis C unresponsive to interferon therapy].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; | 2004 |
[Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cysteine; Disease Progression; Drug Combinations; Drug | 2004 |
2 trials available for glycine and Chronic Hepatitis C
| Article | Year |
|---|---|
Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: a metabolomics analysis.
Topics: Adult; Aged; Antiviral Agents; Area Under Curve; Betaine; Carnitine; Chromatography, Liquid; Drug Th | 2013 |
Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of fibrosis in chronic hepatitis: histopathological correlation.
Topics: Adult; Aged; Aged, 80 and over; Aniline Compounds; Biliary Tract; Case-Control Studies; Female; Glyc | 2010 |
3 other studies available for glycine and Chronic Hepatitis C
| Article | Year |
|---|---|
Physiological and morphoanatomical effects of glyphosate in Eugenia uniflora, a Brazilian plant species native to the Atlantic Forest biome.
Topics: Brazil; Ecosystem; Eugenia; Forests; Glycine; Glyphosate; Hepatitis C, Chronic; Herbicides; Plant Le | 2021 |
P2-P1' macrocyclization of P2 phenylglycine based HCV NS3 protease inhibitors using ring-closing metathesis.
Topics: Antiviral Agents; Cell Line, Tumor; Drug Design; Enzyme Inhibitors; Glycine; Hepacivirus; Hepatitis | 2011 |
[Alternative therapies for hepatitis C: UDCA and SNMC].
Topics: Cysteine; Drug Combinations; Glycine; Glycyrrhetinic Acid; Hepatitis C, Chronic; Humans; Liver; Urso | 2011 |